FindTrial
Sign In

STUDY OF INTERLEUKIN 27 IN DIAGNOSIS OF TUBERCULOUS PLEURISY IN CASES OF PLEURAL EFFUSION.

ROLE OF INTERLEUKIN 27 IN PLEURAL EFFUSION FOR THE DIAGNOSIS OF TUBERCULOUS PLEURISY. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/08/073144
Enrollment
50
Registered
2024-08-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J90- Pleural effusion, not elsewhere classified

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Joint Director of Health Services Leprosy And Tuberculosis
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who have Exudative pleural effusions.

Exclusion criteria

Exclusion criteria: Patients not willing to give consent and non-cooperative. Patients with false positive exudative effusions for e.g., CCF and other associated diseases.

Design outcomes

Primary

MeasureTime frame
Exudative Pleural Effusion samples will be collected using a thoracocentesis techniqueTimepoint: Within 24 hours of hospitalisation—

Secondary

MeasureTime frame
Chest X-ray Complete blood count Electrocardiography Echocardiogram Kidney function test Liver function test Random blood sugarsTimepoint: Within 24 hours of hospitalisation—

Countries

India

Contacts

Public ContactDr Bingu Shiv Kiran Reddy

MBBS, MD RESPIRATORY MEDICINE

bghewade@rediffmail.com9822342770

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026